Advancing Glioma Diagnostics The landscape of neuro-oncology has seen a significant advancement with the recent FDA approval of Pixclara (floretyrosine F 18). This new radioactive diagnostic agent is set to change how clinicians visualize and manage gliomas, which are among the most challenging brain tumors to diagnose and monitor. Understanding Pixclara Pixclara is an amino…